114 related articles for article (PubMed ID: 6745306)
1. Pharmacokinetics of vinpocetine and apovincaminic acid in patients with impaired renal function.
Miskolczi P; Vereczkey L; Szalay L; Göndöcs CS
Eur J Drug Metab Pharmacokinet; 1984; 9(2):169-75. PubMed ID: 6745306
[TBL] [Abstract][Full Text] [Related]
2. Effect of age on the pharmacokinetics of vinpocetine (Cavinton) and apovincaminic acid.
Miskolczi P; Vereczkey L; Szalay L; Göndöc C
Eur J Clin Pharmacol; 1987; 33(2):185-9. PubMed ID: 3691609
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of apovincaminic acid in dogs.
Vereczkey L; Pudleiner P
Pol J Pharmacol Pharm; 1987; 39(2):161-5. PubMed ID: 3432163
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of vinpocetine (Cavinton) in dog.
Polgár M; Vereczkey L
Pol J Pharmacol Pharm; 1984; 36(4):407-12. PubMed ID: 6527972
[TBL] [Abstract][Full Text] [Related]
5. Kinetic metabolism of vinpocetine in the rat.
Vereczkey L; Szentirmay Z; Szporny L
Arzneimittelforschung; 1979; 29(6):953-6. PubMed ID: 582790
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of vinpocetine and its main metabolite apovincaminic acid before and after the chronic oral administration of vinpocetine to humans.
Miskolczi P; Kozma K; Polgár M; Vereczkey L
Eur J Drug Metab Pharmacokinet; 1990; 15(1):1-5. PubMed ID: 2384112
[TBL] [Abstract][Full Text] [Related]
7. Determination of apovincaminic acid in human plasma by gas-liquid chromatography.
Polgár M; Vereczkey L
J Chromatogr; 1982 May; 241(1):29-32. PubMed ID: 7107795
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and comparative bioavailability of two vinpocetine tablet formulations in healthy volunteers by using the metabolite apovincaminic acid as pharmacokinetic parameter.
Vlase L; Bodiu B; Leucuta SE
Arzneimittelforschung; 2005; 55(11):664-8. PubMed ID: 16366040
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of vinpocetine in humans.
Vereczkey L; Czira G; Tamás J; Szentirmay Z; Botár Z; Szporny L
Arzneimittelforschung; 1979; 29(6):957-60. PubMed ID: 582791
[TBL] [Abstract][Full Text] [Related]
10. Study on the absorption of vinpocetine and apovincaminic acid.
Pudleiner P; Vereczkey L
Eur J Drug Metab Pharmacokinet; 1993; 18(4):317-21. PubMed ID: 8020528
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and metabolism of vincamine and related compounds.
Vereczkey L
Eur J Drug Metab Pharmacokinet; 1985; 10(2):89-103. PubMed ID: 3899662
[TBL] [Abstract][Full Text] [Related]
12. Cerebral circulatory and cardiac effects of vinpocetine and its metabolite, apovincaminic acid, in anesthetized dogs.
Imamoto T; Tanabe M; Shimamoto N; Kawazoe K; Hirata M
Arzneimittelforschung; 1984; 34(2):161-9. PubMed ID: 6539108
[TBL] [Abstract][Full Text] [Related]
13. Vinpocetine pharmacokinetics in elderly subjects.
Grandt R; Beitinger H; Schaltenbrand R; Braun W
Arzneimittelforschung; 1989 Dec; 39(12):1599-602. PubMed ID: 2624613
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of metronidazole in patients with varying degrees of renal failure.
Houghton GW; Dennis MJ; Gabriel R
Br J Clin Pharmacol; 1985 Feb; 19(2):203-9. PubMed ID: 3986078
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and metabolic studies of vinpocetine on dogs. I. Pharmacokinetics.
Szeleczky G; Vereczkey L
Pol J Pharmacol Pharm; 1986; 38(3):257-67. PubMed ID: 3774624
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and metabolic studies of vinpocetine on dogs. II. Metabolism.
Szeleczky G; Vereczkey L
Pol J Pharmacol Pharm; 1986; 38(3):269-75. PubMed ID: 3774625
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous evaluation of apovincaminic acid esters and their metabolite apovincaminic acid by solvent partition and GLC in biological samples. Preliminary data with MR 711.
Marzo A; Quadro G; Stradi R; Saccarello ML; Molteni L; Bruno G
Arzneimittelforschung; 1981; 31(10):1681-4. PubMed ID: 7198444
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of sulpiride after intravenous administration in patients with impaired renal function.
Bressolle F; Brès J; Mourad G
Clin Pharmacokinet; 1989 Nov; 17(5):367-73. PubMed ID: 2582694
[TBL] [Abstract][Full Text] [Related]
19. Clinical Pharmacology of Vinpocetine: Properties Revisited and Introduction of a Population Pharmacokinetic Model for Its Metabolite, Apovincaminic Acid (AVA).
Petric Z; Paixão P; Filipe A; Guimarães Morais J
Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896263
[TBL] [Abstract][Full Text] [Related]
20. An open-label study to determine the pharmacokinetics and safety of migalastat HCl in subjects with impaired renal function and healthy subjects with normal renal function.
Johnson FK; Mudd PN; DiMino T; Vosk J; Sitaraman S; Boudes P; France N; Barlow C
Clin Pharmacol Drug Dev; 2015 Jul; 4(4):256-61. PubMed ID: 27136905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
